This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2018-02-09 CDAMG Conference Call"
Jump to navigation
Jump to search
Lisa Nelson (talk | contribs) |
Lisa Nelson (talk | contribs) |
||
Line 71: | Line 71: | ||
========================================================---> | ========================================================---> | ||
===Agenda & Minutes=== | ===Agenda & Minutes=== | ||
− | * Welcome | + | *Welcome |
*Agenda review | *Agenda review | ||
*Approve Minutes of [[2018-01-29_CDAMG_WGM]] | *Approve Minutes of [[2018-01-29_CDAMG_WGM]] |
Revision as of 14:43, 9 February 2018
back to CDA Management Group main page
HL7 CDAMG Minutes Location: Pelican - Riverside Bldg. |
Date: 2018-02-09 Time: 2:00 PM (ET) | ||
Facilitator | Brett | Note taker(s) | Lisa |
Attendee | Name
| ||
George Dixon | |||
Jean Duteau | |||
Rick Geimer | |||
Kai Heitmann | |||
Brett Marquard | |||
Linda Michaelsen | |||
Dale Nelson | |||
Lisa Nelson | |||
Andrew Statler | |||
Quorum: Chair +3 |
Agenda & Minutes
- Welcome
- Agenda review
- Approve Minutes of 2018-01-29_CDAMG_WGM
- Review items
- Discussion Topics
- SWOT
- Reviewed the SWOT
- Any updates as a result of activity at the WGM?
- Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT.
- Asset List - Status, and ongoing management.
- Discuss Status/Development toward CDA Template Interchage Format
- Discuss Status of CDA Template Registry
- Discuss need for & Development of overall CDA Product Roadmap
- Roadmap needs to address questions like:
- Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
- Expectation for CDA R2.0 after CDA R2.1 is released?
- What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
- Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
- Review minutes from 2018-01-29.
- Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
- Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)
- SWOT
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved